Last update :
21/02/2024
Analgesic   Fentanyl citrate  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Anesfent Brazil
Fendrop India
Feniject Iran
Fenodid Chile, Colombia, Mexico
Fenstud Austria
Fentamed Austria, Brazil, Germany, Italy, Spain
Fentanest Chile, Ecuador, Italy, Mexico, Portugal, Spain
Fentanex Colombia, Ecuador, Spain
Fentanyl Australia, Austria, Denmark, Germany, Luxembourg, Saudi Arabia, Tunisia
Fentax Argentina, Ecuador
Filtaten Mexico
Haldid Denmark
Lanzapin Colombia
Leptanal Iceland, Norway, Sweden
Miuron Colombia
Nafluvent Argentina, Colombia
Sintenyl Switzerland
Sublimaze Argentina, Australia, Great Britain, Ireland, New Zealand
Talgesil Malaysia
Talinat Turkey
Utranil Mexico
Stability in solutions   Injection   Stability in solutions : Fentanyl citrate     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 4,55 µg/ml 22°C Light
48 Hour
223
Level of evidence B

Polyvinyl chloride NaCl 0,9% or Glucose 5% 4,55 µg/ml 22°C Light
48 Hour
223
Level of evidence B

Polyvinyl chloride Sodium chloride 0,9% 10 & 50 µg/ml 23°C Not specified
90 Day
4228
Level of evidence B

Polyvinyl chloride Sodium chloride 0,9% 10 & 50 µg/ml 4°C Not specified
90 Day
4228
Level of evidence B

Polyvinyl chloride Sodium chloride 0,9% 20 µg/ml 23°C Not specified
30 Day
222
Level of evidence A

Polyvinyl chloride Sodium chloride 0,9% 20 µg/ml 3°C Not specified
30 Day
222
Level of evidence A

Polyvinyl chloride None 50 µg/ml 22°C Light
28 Day
2031
Level of evidence A

Polyvinyl chloride None 50 µg/ml 25°C Not specified
14 Day
2118
Level of evidence D

Polyvinyl chloride None 50 µg/ml 5°C Protect from light
28 Day
2031
Level of evidence A

Polyolefine Sodium chloride 0,9% 10 µg/ml 22°C Light
93 Day
3916
Level of evidence A

Polyolefine Sodium chloride 0,9% 10 µg/ml 5°C Protect from light
93 Day
3916
Level of evidence A

Polyolefine Sodium chloride 0,9% 10 & 50 µg/ml 23°C Not specified
90 Day
4228
Level of evidence B

Polyolefine Sodium chloride 0,9% 10 & 50 µg/ml 4°C Not specified
90 Day
4228
Level of evidence B

Polyolefine None 50 µg/ml 22°C Light
93 Day
3916
Level of evidence A

Polyolefine None 50 µg/ml 5°C Protect from light
93 Day
3916
Level of evidence A

Polypropylen Syringe NaCl 0,9% or Glucose 5% 10 µg/ml 25°C Not specified
100 Day
4303
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 13 & 34 µg/ml 22°C Not specified
7 Day
929
Level of evidence B

Polypropylen Syringe Sodium chloride 0,9% 13 & 34 µg/ml 38°C Not specified
7 Day
929
Level of evidence B

Polypropylen Syringe Sodium chloride 0,9% 13 & 34 µg/ml 5°C Protect from light
7 Day
929
Level of evidence B

Polypropylen Syringe Sodium chloride 0,9% 20 & 40 µg/ml 23°C Not specified
90 Day
4223
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 5 µg/ml 23-27°C Protect from light
90 Day
2334
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 50 µg/ml 23°C Not specified
90 Day
4223
Level of evidence A

Polypropylen Syringe None 50 µg/ml 22°C Light
28 Day
2031
Level of evidence A

Polypropylen Syringe None 50 µg/ml 25°C Not specified
100 Day
4303
Level of evidence A

Polypropylen Syringe None 50 µg/ml 5°C Protect from light
28 Day
2031
Level of evidence A


  Mentions Légales